JP2013504523A5 - - Google Patents

Download PDF

Info

Publication number
JP2013504523A5
JP2013504523A5 JP2012528249A JP2012528249A JP2013504523A5 JP 2013504523 A5 JP2013504523 A5 JP 2013504523A5 JP 2012528249 A JP2012528249 A JP 2012528249A JP 2012528249 A JP2012528249 A JP 2012528249A JP 2013504523 A5 JP2013504523 A5 JP 2013504523A5
Authority
JP
Japan
Prior art keywords
methyl
trifluoromethyl
group
oxo
dimethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2012528249A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013504523A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2010/005297 external-priority patent/WO2011029537A1/en
Publication of JP2013504523A publication Critical patent/JP2013504523A/ja
Publication of JP2013504523A5 publication Critical patent/JP2013504523A5/ja
Withdrawn legal-status Critical Current

Links

JP2012528249A 2009-09-11 2010-08-28 抗癌薬としての置換(ヘテロアリールメチル)チオヒダントイン Withdrawn JP2013504523A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP09075421.9 2009-09-11
EP09075421 2009-09-11
EP10075069.4 2010-02-17
EP10075069 2010-02-17
PCT/EP2010/005297 WO2011029537A1 (en) 2009-09-11 2010-08-28 Sustituted ( heteroarylmethyl ) thiohydantoins as anticancer drugs

Publications (2)

Publication Number Publication Date
JP2013504523A JP2013504523A (ja) 2013-02-07
JP2013504523A5 true JP2013504523A5 (cg-RX-API-DMAC7.html) 2013-10-17

Family

ID=42782041

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012528249A Withdrawn JP2013504523A (ja) 2009-09-11 2010-08-28 抗癌薬としての置換(ヘテロアリールメチル)チオヒダントイン

Country Status (28)

Country Link
US (1) US20120251551A1 (cg-RX-API-DMAC7.html)
EP (1) EP2475653A1 (cg-RX-API-DMAC7.html)
JP (1) JP2013504523A (cg-RX-API-DMAC7.html)
KR (1) KR20120065396A (cg-RX-API-DMAC7.html)
CN (1) CN102639523A (cg-RX-API-DMAC7.html)
AR (1) AR078166A1 (cg-RX-API-DMAC7.html)
AU (1) AU2010294588A1 (cg-RX-API-DMAC7.html)
BR (1) BR112012005526A2 (cg-RX-API-DMAC7.html)
CA (1) CA2773591A1 (cg-RX-API-DMAC7.html)
CL (1) CL2012000623A1 (cg-RX-API-DMAC7.html)
CO (1) CO6511228A2 (cg-RX-API-DMAC7.html)
CR (1) CR20120113A (cg-RX-API-DMAC7.html)
CU (1) CU20120042A7 (cg-RX-API-DMAC7.html)
DO (1) DOP2012000063A (cg-RX-API-DMAC7.html)
EA (1) EA201200473A1 (cg-RX-API-DMAC7.html)
EC (1) ECSP12011716A (cg-RX-API-DMAC7.html)
IL (1) IL218390A0 (cg-RX-API-DMAC7.html)
IN (1) IN2012DN02081A (cg-RX-API-DMAC7.html)
MA (1) MA33566B1 (cg-RX-API-DMAC7.html)
MX (1) MX2012002977A (cg-RX-API-DMAC7.html)
NZ (1) NZ598643A (cg-RX-API-DMAC7.html)
PE (1) PE20121180A1 (cg-RX-API-DMAC7.html)
PH (1) PH12012500497A1 (cg-RX-API-DMAC7.html)
SG (1) SG178919A1 (cg-RX-API-DMAC7.html)
TN (1) TN2012000108A1 (cg-RX-API-DMAC7.html)
TW (1) TW201111378A (cg-RX-API-DMAC7.html)
UY (1) UY32882A (cg-RX-API-DMAC7.html)
WO (1) WO2011029537A1 (cg-RX-API-DMAC7.html)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3533797B1 (en) 2010-02-17 2023-12-20 Takeda Pharmaceutical Company Limited Heterocyclic compound
AU2011261164A1 (en) * 2010-06-01 2012-12-13 The University Of Queensland Haematopoietic-prostaglandin D2 synthase inhibitors
KR102072041B1 (ko) 2011-12-22 2020-01-31 앨리오스 바이오파마 인크. 치환된 뉴클레오사이드, 뉴클레오타이드 및 그의 유사체
US9441007B2 (en) 2012-03-21 2016-09-13 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
USRE48171E1 (en) 2012-03-21 2020-08-25 Janssen Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
PT2861611T (pt) 2012-05-25 2016-10-11 Janssen Sciences Ireland Uc Nucleósidos de espirooxetano de uracilo
TW201418243A (zh) 2012-11-15 2014-05-16 Bayer Pharma AG 含有磺醯亞胺基團之n-(吡啶-2-基)嘧啶-4-胺衍生物
US9243022B2 (en) 2012-12-21 2016-01-26 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
WO2014153280A1 (en) * 2013-03-22 2014-09-25 Merck Sharp & Dohme Corp. 2-pyridyl carboxamide-containing spleen tyrosine kinase (syk) inhibitors
CN104341351B (zh) * 2013-07-30 2018-02-06 北京海美源医药科技有限公司 一种二芳基硫代乙内酰脲衍生物及其应用
CA3161836A1 (en) * 2013-12-11 2015-06-18 Celgene Quanticel Research, Inc. Inhibitors of lysine specific demethylase-1
CN105829296A (zh) 2013-12-18 2016-08-03 巴斯夫欧洲公司 带有亚胺衍生的取代基的唑类化合物
US9682960B2 (en) * 2013-12-19 2017-06-20 Endorecherche, Inc. Non-steroidal antiandrogens and selective androgen receptor modulators with a pyridyl moiety
CN103896847B (zh) * 2014-04-09 2016-01-20 沈江 一种非甾体类抗雄激素化合物及其制备方法和应用
JP6479854B2 (ja) 2014-05-07 2019-03-06 エヴォテック・インターナショナル・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングEvotec International GmbH 医薬組成物のためのスルホキシイミン置換キナゾリン
TWI656121B (zh) 2014-08-04 2019-04-11 德商拜耳製藥公司 2-(嗎啉-4-基)-1,7-萘啶
CN106187905B (zh) * 2015-05-05 2020-02-21 北京海步医药科技股份有限公司 丁鲁他胺的结晶形式及其制备方法
ES2819869T3 (es) 2015-10-08 2021-04-19 Bayer Pharma AG Nuevos compuestos macrocíclicos modificados
WO2017060322A2 (en) 2015-10-10 2017-04-13 Bayer Pharma Aktiengesellschaft Ptefb-inhibitor-adc
TWI726969B (zh) 2016-01-11 2021-05-11 比利時商健生藥品公司 用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物
EP3601253B1 (en) 2017-03-28 2021-09-15 Bayer Aktiengesellschaft Novel ptefb inhibiting macrocyclic compounds
CA3057891A1 (en) 2017-03-28 2018-10-04 Bayer Aktiengesellschaft Novel ptefb inhibiting macrocyclic compounds
EP3625215B1 (en) 2017-05-18 2023-09-13 PI Industries Ltd Formimidamidine compounds useful against phytopathogenic microorganisms
US11701347B2 (en) 2018-02-13 2023-07-18 Bayer Aktiengesellschaft Use of 5-fluoro-4-(4-fluoro-2-methoxyphenyl)-N-{4-[(S-methylsulfonimidoyl)methyl]pyridin-2-yl}pyridin-2-amine for treating diffuse large B-cell lymphoma
EP3953342B1 (en) 2019-04-11 2025-09-24 University of Miami Improved inhibitors of the notch transcriptional activation complex and methods for use of the same
US20230135524A1 (en) * 2020-01-21 2023-05-04 The United States Of America,As Represented By The Secretary,Department Of Health And Human Services Aryl hydantoin heterocycles and methods of use
WO2022206742A1 (zh) * 2021-03-30 2022-10-06 苏州开拓药业股份有限公司 一种一步法合成乙内酰硫脲衍生物的方法
CN122249431A (zh) * 2023-11-17 2026-06-19 中国药科大学 作为雄激素受体(ar)拮抗剂的化合物及其应用
CN120309588B (zh) * 2025-06-10 2025-08-12 上海健康医学院 一种具有雄激素受体和组蛋白去乙酰化酶6双重抑制作用的乙内酰硫脲类化合物及其用途

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2693461B1 (fr) * 1992-07-08 1994-09-02 Roussel Uclaf Nouvelles phénylimidazolidines substituées, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant.
FR2671348B1 (fr) 1991-01-09 1993-03-26 Roussel Uclaf Nouvelles phenylimidazolidines, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant.
US5411981A (en) 1991-01-09 1995-05-02 Roussel Uclaf Phenylimidazolidines having antiandrogenic activity
USRE35956E (en) 1991-01-09 1998-11-10 Roussel Uclaf Phenylimidazolidines having antiandrogenic activity
FR2694290B1 (fr) 1992-07-08 1994-09-02 Roussel Uclaf Nouvelles phénylimidazolidines éventuellement substituées, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant.
TW521073B (en) 1994-01-05 2003-02-21 Hoechst Marion Roussel Inc New optionally substituted phenylimidazolidines, their preparation process, their use as anti-androgenic agent and the pharmaceutical compositions containing them
FR2716110B1 (fr) 1994-02-16 1996-04-05 Roussel Uclaf Compositions cosmétiques ou pharmaceutiques comprenant des liposomes.
US5656651A (en) 1995-06-16 1997-08-12 Biophysica Inc. Androgenic directed compositions
WO2000017163A1 (en) 1998-09-22 2000-03-30 Yamanouchi Pharmaceutical Co., Ltd. Cyanophenyl derivatives
US6472415B1 (en) 1998-12-18 2002-10-29 Biophysica, Inc. Androgen receptor suppressors in the therapy and diagnosis of prostate cancer, alopecia and other hyper-androgenic syndromes
US6861432B2 (en) 2001-11-23 2005-03-01 Schering Aktiengesellschaft Piperazine derivatives that destabilize androgen receptors
JP2005532291A (ja) 2002-04-12 2005-10-27 ファイザー株式会社 抗炎症薬および鎮痛薬としてのピラゾール化合物
CA2529292A1 (en) 2003-07-02 2005-01-20 Merck & Co., Inc. Oxazolidinone antibiotics and derivatives thereof
AR045955A1 (es) 2003-09-30 2005-11-16 Janssen Pharmaceutica Nv Compuestos benzoimidazolicos
EP2228369A1 (en) 2003-12-23 2010-09-15 Astex Therapeutics Ltd. Pyrazole derivatives as protein kinase modulators
WO2006013887A1 (ja) 2004-08-03 2006-02-09 Chugai Seiyaku Kabushiki Kaisha 新規イミダゾリジン誘導体
KR20070106969A (ko) * 2004-09-09 2007-11-06 추가이 세이야쿠 가부시키가이샤 신규 이미다졸리딘 유도체 및 그 용도
MX2007006387A (es) 2004-12-03 2007-06-20 Hoffmann La Roche Derivados de piridina 3-substituidos como antagonistas h3.
NZ564223A (en) 2005-05-13 2011-03-31 Univ California Diarylhydantoin compounds for treating hormone refractory prostate cancer
US7709516B2 (en) 2005-06-17 2010-05-04 Endorecherche, Inc. Helix 12 directed non-steroidal antiandrogens
NZ596260A (en) 2006-03-29 2013-05-31 Univ California Diarylthiohydantoin compounds
TWI469971B (zh) 2007-10-26 2015-01-21 Univ California 二芳基乙內醯脲類化合物
WO2009097995A1 (de) * 2008-02-07 2009-08-13 Sanofi-Aventis Neue phenyl-substituierte imidazolidine, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung

Similar Documents

Publication Publication Date Title
JP5426543B2 (ja) ピリダジノン誘導体
US9550737B2 (en) TNF -α modulating benzimidazoles
JP5456891B2 (ja) Cyp17阻害剤としての1,3−二置換イミダゾリジン−2−オン誘導体
AU2017260125B2 (en) Aromatic sulfonamide derivatives
CA2483159C (en) Triazole derivatives as tachykinin receptor antagonists
US20100305093A1 (en) Inhibitors of mTOR and Methods of Making and Using
TW202220980A (zh) 新穎二唑系選擇性hdac6抑制劑
AU2008340113B2 (en) Triazole oxadiazoles derivatives
EP2662367B1 (en) Novel indole or indazole derivative or salt thereof
BRPI0511072B1 (pt) compostos derivados de alquinila como moduladores dos receptores de glutamato metabotróbico, seus usos e suas composições farmacêuticas
AU2014262622A1 (en) Benzimidazole derivatives as bromodomain inhibitors
RU2011134868A (ru) N-замещенные насыщенные гетероциклические сульфоновые соединения с активностью агонистов рецептора св2
IL229872A (en) 4trpv antagonists
BG60429B2 (bg) (1н-азол-1-илметил)заместени бензотриазолни производни
AU2013275209A1 (en) Branched chain alkyl heteroaromatic ring derivative
JP2017519818A5 (cg-RX-API-DMAC7.html)
EP2933248A1 (en) Novel renin inhibitor
RU2014132044A (ru) Гетероциклические производные в качестве рецепторов, ассоциированных со следовыми аминами (taars)
WO2005090328A1 (ja) 複素環化合物およびその用途
US7875647B2 (en) Heteroaryl-pyrazole derivatives as cannabinoid CB1 receptor antagonists
EP3227282B1 (en) Novel piperidine derivatives
JP2018111688A (ja) 医薬組成物
WO2019152731A1 (en) Androgen receptor antagonists
JPWO2017007008A1 (ja) 新規イミド誘導体およびその医薬としての用途
WO2026090673A1 (en) Compounds and uses thereof